Fortress Biotech, Inc.
FBIO
$3.86
$0.277.52%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.49M | -10.58M | -6.77M | -12.87M | -10.95M |
| Total Depreciation and Amortization | 1.16M | 1.19M | 1.13M | 957.00K | 1.19M |
| Total Amortization of Deferred Charges | 451.00K | 295.00K | 300.00K | 389.00K | 756.00K |
| Total Other Non-Cash Items | -37.88M | -7.49M | -1.83M | -3.67M | -10.35M |
| Change in Net Operating Assets | -6.78M | -2.98M | -5.73M | -4.87M | -2.48M |
| Cash from Operations | -27.56M | -19.56M | -12.91M | -20.06M | -21.84M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 0.00 | 1.17M | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 6.09M | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -15.00M | -- | -- |
| Cash from Investing | 6.09M | 1.17M | -15.00M | -- | -- |
| Total Debt Issued | -- | -- | 5.00M | 33.67M | 5.00M |
| Total Debt Repaid | 0.00 | -625.00K | -625.00K | -625.00K | -- |
| Issuance of Common Stock | 618.00K | 1.13M | 674.00K | 8.05M | 2.32M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -115.00K | -150.00K | -- | -- | -- |
| Total Dividends Paid | -- | -- | 0.00 | 0.00 | -2.01M |
| Other Financing Activities | 4.02M | 51.79M | 20.76M | -38.38M | 8.95M |
| Cash from Financing | 4.52M | 52.14M | 25.81M | 2.71M | 14.27M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.95M | 33.74M | -2.10M | -17.35M | -7.57M |